LYNPRAZA Olaparib Tablets

LYNPARZA (Olaparib)  is a prescription medicine used to treat adults with ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

Manufacturer :  AstraZeneca

Strengths available :  50mg & 150mg

Storage : Store at temperature  between 15ºC to 25ºC

It is Approved by US FDA

Dosage :

• The recommended dose of Lynparza is 300 mg (two 150 mg tablets) taken orally twice daily, with or
• without food, for a total daily dose of 600 mg.
• The 100 mg tablet is available for dose reduction.
• Continue treatment until disease progression or unacceptable toxicity.
• If a patient misses a dose of Lynparza, instruct patient to take their next dose at its scheduled time.
• Swallow tablets whole. Do not chew, crush, dissolve, or divide tablet.

Common Side effects are Nausea or vomiting , low number of red or white blood cells, tiredness or weakness, sore throat or runny nose, diarrhea, joint, muscle, and back pain, headache, constipation, changes in the way food tastes, loss of appetite, mouth sores, respiratory infections, changes in kidney function blood test, low number of platelets, indigestion or heartburn

112 tablets per bottle (50mg)  &

120 tablets per bottle (150mg)